Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
insulin resistance/carbohydrate
L'enllaç es desa al porta-retalls
Pàgina 1 des de 31 resultats
System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
CROSS-REFERENCE TO RELATED APPLICATIONS
Related subject matter is disclosed in a U.S. patent application of Gordon et al, entitled "A System and Method for Integrating Data with Guidelines to Generate Displays Containing the Guidelines and Data", Ser. No. 09/985,173, filed Nov. 1, 2001; and in a
Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
The present invention relates to the prevention and treatment of carbohydrate and/or fat metabolism disorders in humans and animals.
BACKGROUND OF THE INVENTION
Type 2 diabetes, the most common form of diabetes, is a chronic, progressive metabolic disease. It is characterized by
Carbohydrate composition for flat glucose response
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption.
BACKGROUND OF THE INVENTION
Glucose is an important source of energy to the cells in the human body and is abundantly present in food ingredients. After
Carbohydrate composition for flat glucose response
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption.
BACKGROUND OF THE INVENTION
Glucose is an important source of energy to the cells in the human body and is abundantly present in food ingredients. After
Method and device for assessing carbohydrate-to-insulin ratio
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
A method and a device for sustained medical infusion of therapeutic fluids to patients is described. Some aspects relate to portable infusion devices and to a method for infusion that includes administering a therapeutic fluid to the patient after assessing a diabetic state of
Carbohydrate fraction and use thereof for a flat postprandial glucose response
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF THE INVENTION
The invention relates to a carbohydrate fraction that gives a sustained and lower glucose release after consumption.
BACKGROUND OF THE INVENTION
Glucose is an important source of energy to the cells in the human body and abundantly present in food ingredients. After
Method for lowering insulin resistance
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
BACKGROUND
1. Technical Field
The present invention relates generally to nutrition and more particularly to a method and nutritional composition for improving glucose and insulin balance in an individual. In one embodiment, the invention provides a nutritional composition having a
Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
The present invention relates to a method for predicting the glucose concentration of a subject and recommending therapeutic action.
BACKGROUND
In the United States, approximately three million people have type 1 diabetes..sup.[1] To treat their condition, these patients depend
Method for diagnosing or monitoring carbohydrate metabolism disorders
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
The present invention relates to a method for diagnosing or monitoring carbohydrate metabolism disorders by assaying adiponectin (GBP28) in a sample, a method for monitoring the therapeutic effects of agents for type II diabetes by assaying GBP28 in a sample, a method for assaying
Protein tyrosine phosphate-1B (PTP-1B) deficient mice and uses thereof
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
STATEMENT REGARDING FEDERALLY-SPONSORED R&D
Not applicable
REFERENCE TO MICROFICHE APPENDIX
Not applicable
FIELD OF THE INVENTION
The invention is directed to the field of transgenic mice containing a disrupted PTP-1B gene. The mice may contain a disruption in either one or both copies of the
Newborn infant formulas and feeding methods
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF INVENTION
The present invention relates to infant formulas and methods for using the formulas in feeding newborn infants.
BACKGROUND OF THE INVENTION
There are many different infant nutritional formulas that are commercially available or otherwise known in the infant formula art. These
Newborn infant formulas and feeding methods
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
FIELD OF INVENTION
The present invention relates to infant formulas and methods for using the formulas in feeding newborn infants.
BACKGROUND OF THE INVENTION
There are many different infant nutritional formulas that are commercially available or otherwise known in the infant formula art. These
Real time management of data relating to physiological control of glucose levels
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
TECHNICAL FIELD
The present invention relates generally to an integrated diabetes management system, and more particularly, to the use of exogenous data to predict alarms and to manage glucose levels.
BACKGROUND
Glucose monitoring systems for patients afflicted with diabetes may incorporate various
Process for therapeutically modifying and resetting prolactin rhythm with a dopamine agonist
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
RELATED APPLICATIONS
This is a continuation-in-part of application Ser. No. 463,327 filed Jan. 10, 1990, abandoned, which in turn is a continuation-in-part of application Ser. No. 192,332, filed May 10, 1988; both by Albert H. Meier and Anthony H. Cincotta respectively. Both applications are titled
Therapeutic process for the treatment of the pathologies of type II diabetes
Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
1. FIELD OF THE INVENTION
This invention relates to a process for the reduction in vertebrates, animals or humans, of body fat stores, and reduction of insulin resistance, hyperinsulinemia, which is often associated with insulin resistance, and hyperglycemia, or reduction of plasma glucose. In
La base de dades d’herbes medicinals més completa avalada per la ciència
- Funciona en 55 idiomes
- Cures a base d'herbes recolzades per la ciència
- Reconeixement d’herbes per imatge
- Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
- Llegiu publicacions científiques relacionades amb la vostra cerca
- Cerqueu herbes medicinals pels seus efectes
- Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents
Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades
